DWAC Can’t Seem to Stay out of Trouble

by | Jun 14, 2022

DWAC shares drop 28% on news of a second SEC subpoena. Important merger vote for Sir Richard Branson today. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

More Trouble for DWAC

Shares of Digital World Acquisition Corp. (DWAC) dropped 28% today on news that it has received another subpoena from the SEC related to its planned acquisition of Trump Media & Technology Group. DWAC says the subpoena seeks additional information on “communications regarding and due diligence of of potential targets other than Trump Media & Technology Group and relationships between Digital World and certain advisors, shareholders, as well as certain forward-looking information about TMTG.” DWAC previously disclosed in May a subpoena from the SEC seeking documents and information regarding meetings of the board of directors, the evaluation of potential acquisition targets including TMTG, communications relating to TMTG and payments made to advisors. DWAC shares are down 40% over the past month, versus a 7% decline for the S&P 500 over the same period.

Merger Vote: NLIT / Safe Harbor Financial

Northern Lights Acquisition Corp. (NLIT) sets June 24th vote on Safe Harbor Financial merger. Safe Harbor is a financial services provider to the cannabis industry.

ADER Postpones Vote

26 Capital Acquisition Corp. (ADER) postpones vote on merger with UE Resorts International, citing “illegal occupation and other illegal activities.”

Two merger votes this week, and the usual extensions

Merger vote today for Virgin Group Acquisition Corp. II (VGII) and sustainable consumer products company Grove Collaborative and tomorrow for EJF ACquisition Corp. (EJFA) and AI infrastructure player Pagaya Technologies.

SPAC Daily Movers

Source: Boardroom Alpha

SPAC Calendar

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Research & Analysis

MSP Recovery Sinks

MSP Recovery (MSPR) sinks, falling 53% on its debut. Biote gets approval. Lots of extension votes ahead. And the rest of the day’s news in SPACs.

MSP Recovery Debuts Tomorrow

Medicare and Medicaid secondary payer reimbursement recovery specialist MSP Recovery (MSPR) begins trading tomorrow. Extension for TINV/Grindr. And the rest of the day’s news in SPACs.

Comera Life Sciences Debuts in the Red

Comera Life Sciences (CMRA), the maker of self-injectible biologics, deSPAC’d today, closing down 9%. An updated look at deSPAC count and redemption rates. And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

Sonder’s Francis Davidson on Re-Designing Hospitality and Merger with GMII

For the latest Know Who Drives Return episode, we sat down with Francis Davidson, the founder and CEO of Sonder, a hospitality company that leases and manages travel properties. Sonder is valued at nearly $2B and is going public through Gores Metropolous II. Francis, at just 29 years old, has been able to rapidly scale the company that he founded 8 years ago as a student at McGill University in Quebec. Will Sonder succeed in grabbing a larger share of the lodging space? Have a listen and read our full report on the Sonder deal.

Amy Nauiokas on FinTech VC, SPACs, Diversity, and Anthemis Digital (ADAL)

We were fortunate to sit down with Amy Nauiokas, the Co-Founder, Co-Chair, and Co-CIO of fintech investing platform Anthemis ($1.2B in AUM), who has been a leading fintech investor for nearly 15 years. Though she has a career that us regular folks might find astounding given she also runs a film and television production company, Archer Gray, which promotes story telling from diverse individuals.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.